These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 939921)
41. [Immunogenicity of a recombinant strain of vaccinia virus, expressing a Venezuelan equine encephalomyelitis virus structural protein gene in peroral immunization]. Sviatchenko VA; Kiselev NN; Ryzhikov AB; Bulychev LE; Mikriukova TP; Netesov SV Vopr Virusol; 2000; 45(6):38-41. PubMed ID: 11200645 [TBL] [Abstract][Full Text] [Related]
42. Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia. Ascher MS; Jahrling PB; Harrington DG; Kishimoto RA; McGann VG Clin Exp Immunol; 1980 Aug; 41(2):225-36. PubMed ID: 7438552 [TBL] [Abstract][Full Text] [Related]
43. Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice. Schoneboom BA; Lee JS; Grieder FB J Interferon Cytokine Res; 2000 Feb; 20(2):205-15. PubMed ID: 10714557 [TBL] [Abstract][Full Text] [Related]
44. Radial haemolysis in gel used in serological studies on Venezuelan equine encephalomyelitis virus. Gaidamovich SY; Melnikova EE; Obukhova VR Acta Virol; 1981 Jan; 25(1):36-40. PubMed ID: 6112864 [TBL] [Abstract][Full Text] [Related]
45. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Ferguson JA; Reeves WC; Milby MM; Hardy JL Am J Vet Res; 1978 Mar; 39(3):371-6. PubMed ID: 637386 [TBL] [Abstract][Full Text] [Related]
46. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses. Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002 [TBL] [Abstract][Full Text] [Related]
47. [The immunity generated in white rats vaccinated with strains of the Venezuelan equine encephalomyelitis virus]. Moshkov SP; Grabareva LP; Moshkov AE; Gaĭdamovich SIa Vopr Virusol; 1991; 36(5):417-9. PubMed ID: 1803778 [TBL] [Abstract][Full Text] [Related]
48. Glucan-induced enhancement of host resistance to selected infectious diseases. Reynolds JA; Kastello MD; Harrington DG; Crabbs CL; Peters CJ; Jemski JV; Scott GH; Di Luzio NR Infect Immun; 1980 Oct; 30(1):51-7. PubMed ID: 7439978 [TBL] [Abstract][Full Text] [Related]
49. Gamma-irradiated Venezuelan equine encephalitis vaccines. Reitman M; Tribble HR; Green L Appl Microbiol; 1970 May; 19(5):763-7. PubMed ID: 5463575 [TBL] [Abstract][Full Text] [Related]
50. Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. II. In vitro methods for the measurement and qualitation of the immune response. Adler WH; Rabinowitz SG J Immunol; 1973 May; 110(5):1354-62. PubMed ID: 4697832 [No Abstract] [Full Text] [Related]
51. Venezuelan equine encephalomyelitis vaccine (strain TC-83): a field study. Baker EF; Sasso DR; Maness K; Prichard WD; Parker RL Am J Vet Res; 1978 Oct; 39(10):1627-31. PubMed ID: 717877 [TBL] [Abstract][Full Text] [Related]
52. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis. Vanderwagen LC; Pearson JL; Franti CE; Tamm EL; Riemann HP; Behymer DE Am J Vet Res; 1975 Nov; 36(11):1567-71. PubMed ID: 1190598 [TBL] [Abstract][Full Text] [Related]
54. Adjuvant effects of low doses of a nuclease-resistant derivative of polyinosinic acid . polycytidylic acid on antibody responses of monkeys to inactivated Venezuelan equine encephalomyelitis virus vaccine. Harrington DG; Crabbs CL; Hilmas DE; Brown JR; Higbee GA; Cole FE; Levy HB Infect Immun; 1979 Apr; 24(1):160-6. PubMed ID: 110688 [TBL] [Abstract][Full Text] [Related]
55. Extension of the mean time to death of mice with a lethal infection of Venezuelan equine encephalomyelitis virus by antithymocyte serum treatment. Woodman DR; McManus AT; Eddy GA Infect Immun; 1975 Nov; 12(5):1006-11. PubMed ID: 1104481 [TBL] [Abstract][Full Text] [Related]
56. Cross-protection in hamsters immunized with group A arbovirus vaccines. Cole FE; McKinney RW Infect Immun; 1971 Jul; 4(1):37-43. PubMed ID: 5154876 [TBL] [Abstract][Full Text] [Related]
57. A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques. Chen L; Ewing D; Subramanian H; Block K; Rayner J; Alterson KD; Sedegah M; Hayes C; Porter K; Raviprakash K J Virol; 2007 Nov; 81(21):11634-9. PubMed ID: 17715224 [TBL] [Abstract][Full Text] [Related]
58. Studies of glucose metabolism in rhesus monkeys after Venezuelan equine encephalitis virus infection. Bowen GS; Rayfield EJ; Monath TP; Kemp GE J Med Virol; 1980; 6(3):227-34. PubMed ID: 7014785 [TBL] [Abstract][Full Text] [Related]
59. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Grieder FB; Vogel SN Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925 [TBL] [Abstract][Full Text] [Related]